Remus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '25 Jan 30, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	12,079	10,163	-	-	-	-
Enterprise Value	12,051	10,212	-	-	-	-
Last Close Price	2050.00	1723.15	-	-	-	-
PE Ratio	40.41	47.19	-	-	-	-
PS Ratio	2.65	4.77	-	-	-	-
PB Ratio	12.02	9.74	-	-	-	-
P/TBV Ratio	16.94	13.11	-	-	-	-
P/FCF Ratio	-	342.57	-	-	-	-
P/OCF Ratio	-	282.11	-	-	-	-
EV/Sales Ratio	2.64	4.80	-	-	-	-
EV/EBITDA Ratio	28.40	35.41	-	-	-	-
EV/EBIT Ratio	29.10	36.52	-	-	-	-
EV/FCF Ratio	-	344.23	-	-	-	-
Debt / Equity Ratio	0.17	0.11	0.42	0.03	0.09	0.18
Debt / EBITDA Ratio	0.52	0.40	0.71	0.04	0.21	0.34
Debt / FCF Ratio	-	3.89	3.08	0.04	0.10	0.48
Asset Turnover	-	1.46	1.79	1.84	2.30	-
Inventory Turnover	-	7.62	22.88	8.96	14.50	-
Quick Ratio	1.12	0.96	0.97	0.44	0.58	0.97
Current Ratio	1.82	1.40	1.39	0.84	0.98	1.63
Return on Equity (ROE)	-	42.08%	66.14%	71.37%	40.49%	-
Return on Assets (ROA)	-	11.97%	26.40%	19.63%	8.89%	-
Return on Capital (ROIC)	-	24.45%	39.41%	52.34%	25.48%	-
Return on Capital Employed (ROCE)	30.89%	25.94%	40.27%	63.30%	34.63%	39.34%
Earnings Yield	2.48%	2.12%	-	-	-	-
FCF Yield	0.29%	-	-	-	-
Dividend Yield	0.10%	0.09%	-	-	-	-
Payout Ratio	0.00%	2.74%	-	-	-	-
Buyback Yield / Dilution	-8.32%	-38.79%	-2.10%	-	-	-
Total Shareholder Return	-8.22%	-38.70%	-2.10%	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.